Novo Nordisk Faces Class Claims Over GLP-1 Patent Tactics

By Elliot Weld · January 26, 2026, 4:45 PM EST

A South Carolina drug company has launched a proposed class action against major pharmaceutical company Novo Nordisk, alleging it engaged in anticompetitive behavior to prolong its monopoly against generic competition for...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Value Drug Company v. Novo Nordisk Inc. et al

Case Number

1:26-cv-00420

Court

New York Eastern

Nature of Suit

Anti-Trust

Date Filed

January 23, 2026